We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies.


The West Blog

Latest Post

December 11, 2018

Container Closure Integrity at Low Temperatures

With the help of the FDA’s expedited programs for approval, a new wave of high-value biologic drugs is on the rise in the pharma industry.1 These drugs require cryogenic storage (-80oC to -180oC) to maintain stability. This presents a new challenge: how to measure and demonstrate container closure integrity (CCI) of storage and delivery systems at such low temperatures.</br>
West Pharma

Amy Kim

Specialist, Scientific Communications, TCS

Subscribe to receive the latest blog post
Previous Posts
Vial Seal Stacked on vial

February 09, 2018

Holistic Approach to Container Closure Integrity

Page McAndrew

Page McAndrew

Director, Scientific Communication

West Ready Pack

February 06, 2018

Moisture Considerations for Lyophilized Drug Products

Shi Min Tan

Shi Min Tan

Sr. Technical Account Specialist, TCS

CCI Testing

December 07, 2017

CCI Testing – What You Need to Know

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Global Biologics

Load more